Chloe Bourguignon
Overview
Explore the profile of Chloe Bourguignon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bourguignon C, Laurent J, Lissade-Lavigne G, Chea M, Gris J
Minerva Med
. 2024 Sep;
PMID: 39292215
No abstract available.
2.
Ahmed E, Fieldes M, Bourguignon C, Mianne J, Petit A, Amel N, et al.
Stem Cell Res
. 2024 May;
77:103437.
PMID: 38723411
Human pluripotent stem cells (hiPSC) represent a unique opportunity to model lung development and chronic bronchial diseases. We generated a hiPSC line from a highly characterized healthy heavy smoker male...
3.
Chea M, Bourguignon C, Bouvier S, Nouvellon E, Laurent J, Perez-Martin A, et al.
Eur J Intern Med
. 2023 Dec;
122:47-53.
PMID: 38135584
Background: Intimate partner violence (IPV) targeting women is probably underestimated during a woman's lifetime. Venous thromboembolism (VTE) is a multifactorial disease associated with haemostasis-activating conditions. Minor injuries can trigger VTE....
4.
Bourguignon C, Ansel C, Gineys J, Schuldiner S, Isebe D, Geitner M, et al.
PLoS One
. 2023 Oct;
18(10):e0293356.
PMID: 37883361
In routine hematological instruments, blood cells are counted and sized by monitoring the impedance signals induced during their passage through a Coulter orifice. However, only signals associated with centered paths...
5.
Guillotin F, Mercier E, Fortier M, Bouvier S, Jacquet Q, Dallo M, et al.
J Thromb Thrombolysis
. 2023 Jun;
56(2):351-354.
PMID: 37300604
Over the last decade, the concept of Clonal haematopoiesis of undetermined potential (CHIP) has emerged. Low frequency somatic mutations in hematopoietic cells can occur with age and might allow formation...
6.
Guillotin F, Fortier M, Portes M, Demattei C, Cultrera L, Loyens M, et al.
Thromb Res
. 2022 Dec;
221:65-68.
PMID: 36473363
No abstract available.
7.
Gris J, Bourguignon C, Bouvier S, Nouvellon E, Laurent J, Perez-Martin A, et al.
Thromb Res
. 2022 Sep;
219:102-108.
PMID: 36152459
Introduction: Limitations in the data used to define thromboprophylaxis for patients with antiphospholipid antibodies (aPLAbs) and thrombosis include uncertainties after an initial provoked venous thromboembolic event (VTE). We aimed to...
8.
Gris J, Guillotin F, Chea M, Bourguignon C, Nouvellon E, Bouvier S
Semin Thromb Hemost
. 2022 Sep;
49(4):337-347.
PMID: 36108650
Antiphospholipid antibodies (aPL Abs) have long been associated with the occurrence of certain specific pregnancy morbidities, affecting both mother and fetus. Antithrombotic-based prophylactic regimens are the standard of care. Their...
9.
Ahmed E, Fieldes M, Bourguignon C, Mianne J, Petit A, Jory M, et al.
Cells
. 2022 Aug;
11(15).
PMID: 35954266
Background: Chronic Obstructive Pulmonary Disease (COPD), a major cause of mortality and disability, is a complex disease with heterogeneous and ill-understood biological mechanisms. Human induced pluripotent stem cells (hiPSCs) are...
10.
Gris J, Guillotin F, Chea M, Bourguignon C, Bouvier S
Front Cardiovasc Med
. 2022 Jun;
9:901869.
PMID: 35722088
Pregnancy and puerperium increase the relative risk of venous thromboembolism (VTE) and the absolute risk remains low, around 1 per 1,000, with induced mortality of around 1 per 100,000. Analysis...